Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Yubo International Biotech Limited (YBGJ) had Earnings per Share (EPS) (Basic) of $-0.01 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.01M |
|
$-1.08M |
|
$0.00M |
|
$0.01M |
|
$1.20M |
|
$-1.19M |
|
$-0.00M |
|
$-1.19M |
|
$-1.19M |
|
$-1.19M |
|
$-1.19M |
|
$-1.19M |
|
$-1.19M |
|
$-1.19M |
|
$-1.01M |
|
139.64M |
|
139.64M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.01 |
$-0.01 |
|
| Balance Sheet Financials | |
$0.67M |
|
$0.04M |
|
$0.18M |
|
$0.85M |
|
$2.79M |
|
-- |
|
-- |
|
$2.79M |
|
$-1.94M |
|
$-1.99M |
|
$-1.94M |
|
170.42M |
|
| Cash Flow Statement Financials | |
$-0.84M |
|
-- |
|
$0.85M |
|
$0.01M |
|
$0.01M |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
66.10% |
|
-9614.64% |
|
-9614.64% |
|
-8175.53% |
|
-9616.60% |
|
-8736.73% |
|
$-0.84M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.17 |
|
0.09 |
|
4078.82 |
|
61.10% |
|
59.81% |
|
-140.24% |
|
61.10% |
|
$-0.01 |
|
$-0.01 |
|
$-0.01 |
|